OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons
Jeffrey Fessel
Alzheimer s & Dementia Translational Research & Clinical Interventions (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Jeffrey Fessel
Alzheimer s & Dementia Translational Research & Clinical Interventions (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Showing 13 citing articles:
Challenges and hopes for Alzheimer’s disease
Suren A. Tatulian
Drug Discovery Today (2022) Vol. 27, Iss. 4, pp. 1027-1043
Closed Access | Times Cited: 200
Suren A. Tatulian
Drug Discovery Today (2022) Vol. 27, Iss. 4, pp. 1027-1043
Closed Access | Times Cited: 200
Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease
Chanchal Sharma, Sehwan Kim, Youngpyo Nam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4850-4850
Open Access | Times Cited: 147
Chanchal Sharma, Sehwan Kim, Youngpyo Nam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4850-4850
Open Access | Times Cited: 147
Alzheimer's and Parkinson's disease therapies in the clinic
Puja Chopade, Neha Chopade, Zongmin Zhao, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 96
Puja Chopade, Neha Chopade, Zongmin Zhao, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 96
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 64
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 64
Self-Amplifying RNA Approach for Protein Replacement Therapy
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12884-12884
Open Access | Times Cited: 38
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12884-12884
Open Access | Times Cited: 38
A mechanistic survey of Alzheimer's disease
Yijing Tang, Dong Zhang, Xiong Gong, et al.
Biophysical Chemistry (2021) Vol. 281, pp. 106735-106735
Open Access | Times Cited: 45
Yijing Tang, Dong Zhang, Xiong Gong, et al.
Biophysical Chemistry (2021) Vol. 281, pp. 106735-106735
Open Access | Times Cited: 45
MicroRNA Networks in Cognition and Dementia
Grace S. Blount, Layton Coursey, Jannet Kocerha
Cells (2022) Vol. 11, Iss. 12, pp. 1882-1882
Open Access | Times Cited: 27
Grace S. Blount, Layton Coursey, Jannet Kocerha
Cells (2022) Vol. 11, Iss. 12, pp. 1882-1882
Open Access | Times Cited: 27
Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy
Jeffrey Fessel
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Jeffrey Fessel
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells
Miranda Robbins
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2633-2637
Open Access | Times Cited: 9
Miranda Robbins
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2633-2637
Open Access | Times Cited: 9
Mitochondria-Targeting Cu2-xSe-TPP with Dual Enzyme Activity Alleviates Alzheimer's Disease by Modulating Oxidative Stress
Liqiang Wang, Xiaoyu Yuan, Qianyu Cai, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114244-114244
Closed Access | Times Cited: 1
Liqiang Wang, Xiaoyu Yuan, Qianyu Cai, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114244-114244
Closed Access | Times Cited: 1
Summary of the Current Status of DNA Vaccination for Alzheimer Disease
Caterina Vicidomini, Nicola Borbone, Valentina Roviello, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1706-1706
Open Access | Times Cited: 3
Caterina Vicidomini, Nicola Borbone, Valentina Roviello, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1706-1706
Open Access | Times Cited: 3
Prevention of Alzheimer's dementia may be within reach
Jeffrey Fessel
Clinical and Translational Discovery (2022) Vol. 2, Iss. 2
Open Access
Jeffrey Fessel
Clinical and Translational Discovery (2022) Vol. 2, Iss. 2
Open Access
